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βigh3 (keratoepithelin), also known as TGFβ1, is a trans-
forming growth factor-β (TGF-β)-induced extracellular ma-
trix (ECM) protein that was first identified in human adeno-
carcinoma cells [1]. βigh3 is strongly induced by TGF-β in
several cell lines including human epithelial cells,
keratinocytes, and fibroblasts [2,3]. βigh3 is ubiquitously ex-
pressed in many normal human tissues such as the heart, liver,
pancreas, and skin, suggesting that it may have an important
function throughout the body [1]. It has been reported that
βigh3 is not only expressed in the cornea of the normal hu-
man eye but also in healing corneal wounds [4-6]. During
mouse development, expression of βigh3 in the cornea begins
around embryonic day 15.5 (E15.5) and is sustained until E18.5
with localization in the corneal epithelium and stroma [7].
Mutations of βigh3 are responsible for 5q31-linked hu-
man autosomal dominant corneal dystrophies such as granu-
lar corneal dystrophy (GCD), Reis-Bückler corneal dystro-
phy (RBCD), lattice corneal dystrophy (LCD) type I and IIIA,
and Avellino corneal dystrophy (ACD) [8,9]. These diseases
are most often characterized by progressive accumulation of
deposits in the cornea, resulting in a loss of transparency and
severe visual impairment. Although mutations of βigh3 are
well described in corneal dystrophy, the function of normal
βigh3 in the eye is not well known. We recently reported that
normal βigh3 mediates human corneal epithelial cell adhe-
sion through α3β1 integrin [10] and that βigh3 and its mu-
tants polymerize to form a fibrillar structure and interact with
type I collagen, laminin, and fibronectin [11].
TGF-β is a multifunctional cytokine that regulates cell
growth and differentiation as TGF-β inhibits epithelial cell
proliferation and stimulates the proliferation of smooth muscle
cells and skin fibroblasts [12,13]. TGF-β and its receptors are
localized in the human anterior segment of the eye, including
the cornea, and may regulate various pathophysiological re-
©2007 Molecular Vision
Anterior segment dysgenesis after overexpression of transforming
growth factor-β β β β β-induced gene, β β β β βigh3, in the mouse eye
Jung-Eun Kim,1 Min-Su Han,2 Yong-Chul Bae,3 Hong-Kyun Kim,4 Tae-Im Kim,5,6 Eung Kweon Kim,5,6 In-San
Kim2
(The first two authors contributed equally to this publication)
1Department of Molecular Medicine, Kyungpook National University School of Medicine, 2Cell and Matrix Research Institute,
Department of Biochemistry and Cell Biology, Kyungpook National University School of Medicine, Daegu, 700-422, Korea, 3De-
partment of Oral Anatomy, Kyungpook National University School of Dentistry, Daegu, 700-412, Korea, 4Department of Ophthal-
mology, Kyungpook National University School of Medicine, Daegu, 700-422, Korea, 5Corneal Dystrophy Research Institute, De-
partment of Ophthalmology, Yonsei University College of Medicine, 6BK21 Project Team of Nanobiomaterials for Cell-based Im-
plants, Yonsei University, Seoul, 120-752, Korea
Purpose: βigh3 is a transforming growth factor-β-inducible cell adhesion molecule and its mutations are responsible for
human autosomal dominant corneal dystrophies. Previously, we have studied the molecular properties of βigh3 in vitro
and reported that βigh3 polymerizes to form a fibrillar structure and interacts with several extracellular matrix proteins
including type I collagen. This study aimed to understand the role of elevated circulating levels of normal βigh3 in eye
development and corneal diseases.
Methods: We generated Alb-hβigh3 transgenic mice that have liver-specific expression of human βigh3 (hβigh3) under
the control of the albumin (Alb) enhancer/promoter and investigated the influence of βigh3 overexpression in mouse eye.
Polymerase chain reaction (PCR) genotyping, western blotting, and ELISA were performed to generate Alb-hβigh3
transgenic mouse lines. To identify the ocular pathology, electron microscopy and histological staining were employed in
Alb-hβigh3 transgenic mice and wild-type mice.
Results: Normal hβigh3 was ectopically overexpressed in the liver, secreted into blood stream, and reached the cornea of
Alb-hβigh3 transgenic mice. Among transgenic mice, some mice had anterior segment defects including corneal opacity,
disorganization of the collagen layers in the corneal stroma, and corneolenticular adhesion.
Conclusions: These results suggest that βigh3 may be involved in anterior segment morphogenesis and eye development
in mice. In addition, this indicates that the level of normal βigh3 expression must be properly maintained during ocular
development. The phenotype observed in Alb-hβigh3 transgenic mice is similar to human eye disorders such as anterior
segment dysgenesis and Peters’ anomaly. Thus, this model provides a very useful tool to study human eye diseases and the
control of proliferation and differentiation of neural crest-originated cells.
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1942sponses in the anterior segment by controlling cell prolifera-
tion, differentiation, and ECM composition [14,15]. Moreover,
TGF-β highly induces βigh3, which associates with ECM
molecules. Based on the expression of TGF-β and βigh3 in
the eye and their correlation, βigh3 as well as TGF-β may be
key molecules in the pathogenesis of ocular disorders or in
the eye development.
In this study, to characterize the role of βigh3 responses
in ocular development, we generated transgenic mice that have
liver-specific expression of normal βigh3 under the control of
the albumin (Alb) enhancer/promoter [16] and we investigated
in the eyes of these mice the influence of overexpressed nor-
mal βigh3 secreted from the liver. The data from this study
showed that the elevated levels of normal βigh3 caused cor-
neal opacity and anterior segment dysgenesis. Therefore, these
results had particular relevance for human fetal conditions
characterized by ocular abnormalities such as anterior seg-
ment mesenchymal dysgenesis. The results established an
experimental model in which overexpression of normal βigh3
resulted in the gross ocular pathophysiological characteristics
of these conditions.
METHODS
Animals:  All procedures concerning animal experiments in
the present study were conducted according to the guidelines
of Kyungpook National University. All mice were maintained
on 12 h light/dark cycles in specific pathogen free (SPF) con-
ditions and fed a sterilized standard diet.
Construction of the Alb-hβigh3 transgene and genera-
tion of transgenic mice:  To generate an Alb-hβigh3 transgene,
a SalI/XhoI fragment of a full-length human βigh3 (hβigh3,
amino acids 1-683), which has high identity with mouse βigh3,
was first cloned into the SalI site of a plasmid that has a 4.3 kb
fragment of IRES-LacZ-mp1 intron/polyA. After insertion of
hβigh3, a 2.3 kb fragment of the albumin (Alb) enhancer/pro-
moter (kindly provided by Dr. R. Palmiter, Seattle, WA) [16],
which is essential for expression in the liver, was cloned into
the NotI/SalI site at the 5'-end of hβigh3-IRES-LacZ-mp1 in-
tron/polyA. The entire construct was cut with NotI and NruI
and the 8.8 kb transgene named Alb-hβigh3 was purified. Pu-
rified Alb-βigh3 transgene was injected into the pronucleus
of fertilized eggs of C57BL/6 embryos by Macrogen Inc.
(Seoul, Korea). Two hundred animals were screened and seven
founders were identified that exhibited integration of the Alb-
hβigh3 transgene by polymerase chain reaction (PCR)
genotyping. Transgenic founders were backcrossed to C57BL/
6 or intercrossed. The transgenic mice and their wild-type
control littermates were maintained under standard tempera-
ture and lighting.
Identification of transgenic mice by genotype analysis:
The transgene in Alb-hβigh3 founders and offspring was iden-
tified by PCR analysis of genomic DNA obtained from tail
biopsies. PCR was performed in 30 µl reaction mixtures, each
containing 100 ng genomic DNA, 0.2 µM each primer set, 1
mM dNTP mixture, 3 µl of 10X Taq buffer, and 1 unit of Taq
polymerase. The primers were specific for hβigh3 cDNA (for-
ward: 5'-TCA TCG ATA AGG TCA TCT CC-3', reverse: 5'-
CGG TTC AAA GTC TCA CTA GG-3') and LacZ cDNA (for-
ward: 5'-TAA TCA CGA CGC GCT GTA TC-3', reverse: 5'-
CGG ATA AAC GGA ACT GGA AA-3') to amplify a 202 bp
and 500 bp fragment, respectively. Amplification was per-
formed for 35 cycles in the following PCR conditions: one
min at 95 °C, one min at 48 °C for hβigh3 and at 58 °C for
LacZ, and one min at 72 °C using a GeneAmp PCR System
9600 (PE Applied Biosystems, Foster City, CA). PCR prod-
ucts were then separated electrophoretically on 1% agarose
gels and visualized after ethidium bromide staining. Primers
for glyceraldehyde-3-phosphate dehydrogenase (GAPDH;
forward: 5'-TGA AGG TCG GTG TGA ACG ATT TGG C-3',
reverse: 5'-CAT GTA GGC C-AT GAG GTC CAC CAC-3')
were used as a PCR control.
Western blotting for human βigh3 in the liver:  Liver and
eye from wild-type and transgenic mice was prepared in
radioimmunoprecipitation assay (RIPA) lysis buffer includ-
ing 150 mM NaCl, 10 mM Tris pH 7.2, 0.1% SDS, 1% Triton
X-100, 1% Deoxycholate, and 5 mM EDTA. Each sample was
mixed with 2X sample buffer (100 mM Tris-HCl, pH 6.8, 200
mM dithiothreitol, 4% SDS, 0.2% bromophenol blue, and 20%
glycerol) and boiled for 10 min. Then, the samples were sepa-
rated by 10% sodium dodecyl sulfate-PAGE and transferred
to nitrocellulose membrane (GE Healthcare, Buckinghamshire,
UK). Blocking was performed with 5% nonfat milk in phos-
phate-buffered saline (PBS) for 1 h at room temperature (RT).
The membrane was incubated for 2 h at RT with anti-human
βigh3 antibody (diluted 1:1000 in PBS), and then reacted for
1 h at RT with peroxidase-conjugated anti-rabbit IgG anti-
body (diluted 1:3000 in PBS; Santa Cruz Biotechnology, Santa
Cruz, CA). The blot was developed with Super Signal West
Pico Chemiluminescent Substrate (Pierce, Rockford, IL). Anti-
β-actin antibody was used as a control on the same filter after
deprobing.
Immunohistochemistry of human βigh3 in the liver and
eye:  To investigate transgenic expression, immunohistochemi-
cal staining of the mouse liver and eye was performed as de-
scribed previously [17]. Briefly, sections were deparaffinized,
rehydrated, and blocked by incubation in 10% H2O2 before
blotting. The sections were then put in 1 mM Tris solution
(pH 9.0) supplemented with 0.5 mM EGTA and heated in a
microwave for 10 min to reveal the antigens. After blocking
in PBS, supplemented with 1% BSA, 0.05% saponin, and 0.2%
gelatin, sections were incubated overnight at 4 °C with anti-
human βig-h3 antiserum in a humidified chamber. Sections
were then washed three times and incubated with horseradish
peroxidase-conjugated goat anti-rabbit immunoglobulins
(DAKO, Glostrup, Denmark) for 90 min at RT. The signal
was visualized by incubating the sections with liquid
diaminobenzidine tetrahydrochloride (DAB) Chromogen
(DAKO). Hematoxylin staining was used to counterstain sec-
tions.
Enzyme-linked immunoSorbent assay of human βig-h3 in
blood:  The level of human βigh3 in mouse plasma was mea-
sured by enzyme-linked immunosorbent assay (ELISA; Regen
Biotech, Seoul, Korea). Blood was collected through the saphe-
nous vein into potassium EDTA-coated Microvette tubes
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(Sarstedt, Nümbrecht, Germany). Recombinant human βigh3
proteins and the anti-human βigh3 antibody for ELISA were
prepared as described previously [10]. For ELISA, 96 well
plastic flat microtiter plates (Corning, Lowell, MA) were
coated overnight at 4 °C with wild-type human βigh3 protein
in 20 mM carbonate-bicarbonate buffer (pH 9.6) with 0.02%
sodium azide. The coated plates were then washed with PBS
with 0.05% Tween-20 (PBS-T). Mouse plasma samples were
diluted in PBS-T and preincubated with anti-human βigh3 an-
tibodies in 96 well plastic round microtiter plates for 90 min
at 37 °C. The preincubated samples were then transferred to
the precoated plates and incubated for 30 min at RT. Thereaf-
ter, the samples were incubated with the peroxidase-conju-
gated anti-rabbit IgG antibodies (Santa Cruz Biotechnology)
for 90 min at RT, and the plates were washed as before. The
assay was developed with a substrate solution of 0.1 mg/ml o-
phenylenediamine and 0.003% H2O2 for 60 min at RT in the
dark. After stopping the reaction with 8 N H2SO4, the absor-
bance was read at 492 nm in a Bio-Rad model 550 microplate
reader. The paired t-test was used to determine statistical sig-
nificance with p<0.05 considered to denote statistical signifi-
cance. Values were expressed as mean±SD.
Gross pathology and ocular stereology:  To analyze the
gross appearance of the eye, enucleated mouse eyeball samples
were examined under a slit lamp biomicroscope (Haag-Streit,
Bern-Koeniz, Switzerland) equipped with a digital camera;
images were captured with the eye image capture system
(eMedio®Inc., Seoul, Korea). To capture cataracts, pupils were
dilated with a drop of 1% Mydriacyl (Alcon Laboratories,
Hemel Hempstead, UK) for 20-30 min while the animals were
under anesthesia. The eyeball sizes were observed under a ste-
reomicroscope with a ruler.
Light microscopy:  For the histological analysis of the
cornea, enucleated mouse eyeballs were fixed in 4% paraform-
aldehyde (PFA) in PBS for 16 h at 4 °C, dehydrated in a graded
series of ethanol, and then embedded in paraffin. Serial sec-
tions, including anterior segment defects in the eyes of Alb-
hβigh3 transgenic mice, were cut at 4 µm thickness and stained
with hematoxylin and eosin (H&E) or with Masson’s
trichrome. Masson’s trichrome stained collagen fibers blue and
most other intracellular and extracellular proteins red.
Electron microscopy:  Corneas were fixed in 2.5% glut-
araldehyde in 0.1 M phosphate buffer (PB, pH 7.4) for 2-4 h
at 4 °C. The central portion of the cornea, including the opaque
region, in Alb-hβigh3 transgenic mice was removed, washed
three times in 0.1 M PB, and post-fixed in 1% osmium tetrox-
ide in 0.1 M PB for 2 h at 4 °C. After rinsing with 0.1 M PB,
the samples were dehydrated in a graded series of ethanol,
immersed in propylene oxide, infiltrated with an Epon mix-
ture, embedded in a Beem capsule, and polymerized for three
days. Serial ultrathin sections were cut with an ultramicro-
tome, collected on Formvar film-coated single slot nickel grids,
and counterstained with uranyl acetate and lead citrate. The
grids were examined on a Hitachi H6000 electron microscope
at 80 kV accelerating voltage.
RESULTS
Transgenic mice overexpressing normal hβigh3 in the liver
and blood:  The mouse albumin (Alb) enhancer/promoter was
used to generate transgenic mice expressing human βigh3
(hβigh3) in the liver with increased levels of hβigh3 in the
blood. The full-length hβigh3 was inserted into the plasmid
with Alb enhancer/promoter, followed by IRES-LacZ-mp1
intron/polyA to detect β-galactosidase activity in the liver (Fig-
ure 1A). This NotI/NruI transgene fragment was injected into
fertilized eggs of C57BL/6 and then 200 animals from injected
eggs were screened to select transgenic founders. Seven
founder mice were identified and three of these lines showed
high expression of the transgene. To maintain the lines, they
were crossed with C57BL/6 and the offspring were identified
by PCR genotyping of hβigh3 and LacZ gene 10 days after
birth (Figure 1B). PCR results showed 202 bp and 500 bp
PCR products for hβigh3 and LacZ, respectively. To investi-
gate ectopic expression of the hβigh3 transgene, western blot-
ting and immunohistochemistry were performed in the liver
and eye of two-month-old mice using anti-human βigh3 anti-
body. High expression of hβigh3 was detected by western blot
analysis in the liver and in eye extracts of transgenic mice
(Figure 1C). Transgenic mice also showed strong expression
of the hβigh3 transgene in liver hepatocytes and in corneal
epithelium by immunostaining (Figure 1D). Figure 1B-D show
representative data for hβigh3 transgene expression in 28
transgenic mice. ELISA was completed for hβigh3 in plasma
and the level of hβigh3 in 28 transgenic mice was 1.5-2 fold
higher than in 19 wild-type mice (Figure 1E). A high level of
hβigh3 expression was also observed by western blot analysis
in the plasma of transgenic mice (Figure 1E). As the human
βigh3 antibody partially cross-reacted with both mouse and
human βigh3, the amount in wild-type mice likely represented
the level of endogenous mouse βigh3 in tissue and blood. Fi-
nally, we generated Alb-hβigh3 transgenic mice that
overexpress hβigh3 under the control of the Alb enhancer/
promoter. Stable transgenic mice were continuously propa-
gated in the C57BL/6 background to maintain the lines and to
analyze the phenotype.
Gross phenotype and electron microscopic examination
of the mice eyes with hβigh3 overexpression:  Among the Alb-
hβigh3 transgenic mice identified by PCR genotyping 10 days
after birth, eight transgenic mice displayed a central corneal
opacity, a characteristic phenotype that was visible when the
eyelids opened around two weeks after birth. At the age of
two months, when plasma could safely be collected, the level
of hβigh3 was measured in all wild-type and transgenic mice
to establish hβigh3 overexpression in plasma. The average
bodyweight and eye size were identical for wild-type (22±0.6
g, 3.5±0.05 mm) and transgenic mice (22±0.4 g, 3.5±0.08 mm)
at two months of age. Internal organs such as the liver and
kidney were phenotypically normal (data not shown) and there
was no specific phenotype, even in the liver where ectopic
normal βigh3 was produced under control of the albumin pro-
moter (Figure 1D). This was performed through systematic
1944sampling and measurements in all wild-type and transgenic
mice. Even though the bodyweight and the size of eyes were
no different between wild-type and transgenic mice, various
phenotypes with diverse defect sizes were investigated in the
defective eye of transgenic mice that had a corneal opacity
(Figure 2). The gross ocular phenotypes of Alb-hβigh3
transgenic mice showed corneal opacification (Figure 3B). The
opacity sometimes accompanied a cataract, which was inves-
tigated in the eye of transgenic mice after pupil dilatation (Fig-
ure 3C). These anomalies were never seen in normal eyes of
wild-type mice (Figure 3A). Corneal opacity was observed
bilaterally with cataracts in Alb-hβigh3 transgenic mice with
eye defects. Among eight Alb-hβigh3 transgenic mice with
corneal opacity, bilateral defects with cataracts were observed
in five mice and unilateral defect was shown in the remaining
three mice. Electron microscopy showed that the collagen fi-
bers and fibrils were disorganized with an irregular arrange-
ment in the corneal stroma of the defected eye in transgenic
mice compared to the stroma in wild-type mice, which were
compact and well-organized (Figure 4A). Additionally, tissue
debris was frequently observed in the spaces among the disor-
ganized collagen fibers (Figure 4B).
Histological analysis of the anterior segment:  Ocular his-
tology was analyzed in the eyes of wild-type and Alb-hβigh3
transgenic mice. Though the extent of the defect varied in each
transgenic mouse, all mutant eyes had abnormalities at layers
of the cornea, anterior chamber, and lens. In H&E stained sec-
tions, normal cornea was separated from the lens by a distinct
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Figure 1. Generation of Alb-hβigh3 transgene.  A: The diagram of
Alb-hβigh3 transgene shows the albumin enhancer/promoter (Alb
E/P), the human βigh3 (hβigh3), and IRES-LacZ-mp1 intron/polyA
(IRES-LacZ-mp1/pA). NotI and NruI indicate enzyme sites in the
transgene for pronuclear injection. B: PCR genotyping for hβigh3
and LacZ gene in wild-type (wt) and transgenic (tg) mice. The 202-
bp hβigh3 and 500 bp LacZ amplification products were produced
by PCR in Alb-hβigh3 transgenic mice. PCR for glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was performed as a control. M
and F indicate a DNA size marker and a founder mouse as a positive
control for PCR, respectively. C: Western blot analysis of hβigh3
expression in liver and eye extracts from wild-type (wt) and transgenic
(tg) mice. The hβigh3 protein was highly expressed in the transgenic
mouse compared to the wild-type mouse. β-Actin was used as an
internal protein control. D: Immunohistochemical study of wild-type
(wt) and transgenic (tg) liver and cornea at two months of age using
anti-human βigh3 antibody. Expression of hβigh3 transgene was
strongly detected in liver hepatocytes and corneal epithelium of Alb-
hβigh3 transgenic mouse. Abbreviations: H, hepatocyte; V, terminal
hepatic venule; Ep, corneal epithelium; S, corneal stroma; En, cor-
neal endothelium. E: Human βigh3 levels in plasma of wild-type
(wt) and transgenic (tg) mice. ELISA showed that hβigh3 levels in
plasma were elevated two-fold in transgenic mice. The plasma lev-
els show the average for 19 wild-type mice and 28 transgenic mice.
High expression of hβigh3 protein was detected in plasma of
transgenic mice by western blotting. The asterisk indicates a statisti-
cally significant difference (p<0.001) calculated by paired t-test. The
western blotting and ELISA data are representative of three indepen-
dent experiments.
1945endothelial layer and the corneal epithelium showed well-de-
fined, stratified squamous epithelium with a smooth surface
(Figure 5A, Figure 6A). In comparison, transgenic mice with
corneal opacity displayed an obvious abnormal cornea with
an irregular corneal epithelium and an uneven corneal stroma,
including disorganization of collagen layers in the defective
area (Figure 6B,C). The defective eye also had a narrow ante-
rior chamber and showed either partially formed or discontin-
ued corneal endothelium (Figure 5B,C). Unlike the thin mono-
layer of lens epithelial cells in the lens’ anterior surface of
wild-type mice, the anterior region of the lens had abnormal
multilayer cells in transgenic mice (Figure 5).
In another transgenic mouse that showed more serious
deformity of the eye (Figure 7), the separation between lens
and cornea was not complete. The anterior portion of the lens
attached to the posterior surface of the cornea and the anterior
chamber was obliterated with the iris adherent to the posterior
surface of the cornea. Proliferated lens epithelial cells under
the lens capsule were observed in the attached portion between
the protruded lens and cornea. Thin corneal epithelium and
disordered corneal stroma were also observed in the defective
eye of the transgenic mouse. As shown in the wild-type mouse
of Figure 5, the cornea was separated from the lens by a dis-
tinct endothelial layer; this was also the case in the seven-
month-old wild-type mouse (Figure 7E).
DISCUSSION
 A transforming growth factor-β (TGF-β)-induced extracellu-
lar matrix (ECM) protein, βigh3, has been considered a major
component of abnormal extracellular deposits in the cornea
and its mutations and responsible for 5q31-linked human au-
tosomal dominant corneal dystrophies (CDs) [8]. Immuno-
histochemical studies show that βigh3 is strongly stained in
pathologic deposits in all mutant βigh3-related corneal dys-
trophies and that, above all, high levels of normal βigh3 are
detected in scarring cornea [18] as if TGF-β is present on the
edge of wound healing in the cornea [19]. These data suggest
that βigh3 as well as TGF-β would be key molecules in the
pathogenesis of corneal opacification. In this study, we inves-
tigated whether βigh3 is essential to ocular development in
vivo and whether it is pathologically important to corneal dis-
organization.
First, to study the function of βigh3 in eye, it is necessary
to discover suitable methods or animal models that express
ectopic or mutant βigh3. Many researchers have tried direct
injections or eye drops of plasmid DNA or infection with an
adenovirus vector in the eye. However, the difficulty of gene
transfer into the cornea or the eye without inflammation pre-
vents the study of certain protein’s roles in these tissues [20,21].
Therefore, diverse methods to overcome this difficulty have
been studied and reported. Several mouse model systems have
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Figure 2. Gross appearance of
wild-type and Alb-hβigh3
transgenic mouse.  The eye of
a two-month-old transgenic
mouse (B) had a corneal opac-
ity with a characteristic phe-
notype compared to wild-type
(A). C and D show the left
eyes with corneal opacity in
one-year-old Alb-hβigh3
transgenic mice.
1946been developed to observe the function of TGF-β, which is an
inducer of βigh3 and has a critical role in the development of
normal cornea [22,23]. Even though overexpression of TGF-
β1 driven by the lens-specific αA-crystallin promoter does
not cause a corneal phenotype in the embryonic mouse eye,
cataract formation is observed in adult mice with ocular de-
fects including corneal opacity and structural changes in the
iris and ciliary body [24]. Transgenic overexpression of TGF-
β1 by lens-specific chicken βB1-crystallin promoter also re-
vealed severe disruption of corneal and anterior chamber de-
velopment from mouse embryonic day 13.5 [25]. These re-
sults suggest not only the importance of precise quantitative
control of TGF-β but also of good transgenic model systems
to study the role of TGF-β in eye development. However, TGF-
β overexpression regulated by these specific promoters may
cause an artificial and excessive phenotype that is restricted
to a specific time and tissue in lens development.
Sakamoto et al. [26] constructed an adenoviral vector ex-
pressing a soluble TGF-β receptor fused to the Fc portion of
human IgG and injected this construct into the skeletal muscle
of mice. The soluble TGF-β receptor produced in the muscle
reached the cornea by means of normal blood circulation, se-
questered local TGF-β, and acted in the cornea but not in the
lens. Based on this idea, we generated transgenic mice that
overexpressed human βigh3 (hβigh3) in blood through the
liver-specific albumin (Alb) enhancer/promoter. Albumin,
which is a major secretory protein of the liver, is induced in
fetal liver and its expression is maintained in the adult liver
[27]. Since serum albumin is synthesized particularly by hepa-
tocytes, the albumin promoter/enhancer is activated during
liver development. Previously, it had also been reported that
the most abundant water-soluble protein in the human cornea,
serum albumin, can diffuse from peripheral blood vessels
around the cornea [28,29]. βigh3 is a secretory protein and
hβigh3 ectopically expressed in liver under the control of Alb
promoter was able to secrete into blood. Eventually, this se-
creted protein reached the cornea via blood vessels surround-
ing the limbal area of the cornea where it affected the anterior
segment. In this model system, we can exclude possible artifi-
cial outcomes in the lens caused by using αA- or βB1-crystal-
lin lens-specific promoters and explain the role of βigh3, which
causes corneal diseases in human.
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Figure 3. Phenotypes in two-month-old Alb-hβigh3 transgenic mouse eye.  A and D: Normal eye of a wild-type mouse. A and D are a lateral
view and a frontal view of the eye with transparent cornea, respectively. B and E: Mutant eye with corneal opacity in Alb-hβigh3 transgenic
mouse. B and E show different angle views of the defective eye in the transgenic mouse. The Red arrow indicates the corneal opacification and
the red arrowhead indicates the relatively clear zone in the transgenic mouse. C and F: The mutant eye with cataract in Alb-hβigh3 transgenic
mouse. C and F show different angle views of the eye with cataract in the transgenic mouse. The white arrow indicates cortical opacity of the
lens. The scale bars are equal to 0.5 mm.
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Figure 4. Electron micrographs
showing stroma of central portion
of cornea in wild-type and Alb-
hβigh3 transgenic mice.  Corneas
from mice were fixed in 2.5% glu-
taraldehyde and subjected to elec-
tron microscopy. A and C: In wild-
type mice, collagen fibers and
fibrils were regularly and com-
pactly arranged parallel to the epi-
thelial surface. However, in Alb-
hβigh3 transgenic mice (B and D),
the collagen fibers and fibrils were
disorganized. Tissue debris was
occasionally observed between
the collagen fibers (arrowhead). A
and B are images corresponding
to 5K and C and D are images cor-
responding to 8K. The scale bars
are equal to 2 µm. Abbreviations:
C, collagen layers; S, stromal
cells.
Figure 5. Histopathologic findings of normal eye in wild-type mouse and the defective eye in transgenic mouse at two months of age.  Staining
was performed with H&E in each 4 µm thick paraffin section. C is the serial section of B. Images in row 2 are higher-magnification images
corresponding to small red rectangles in row 1. The abnormal cornea of transgenic mice (B, C) had disorganized corneal stroma, disconnected
corneal endothelium, and a narrow anterior chamber compared to wild-type (A). The anterior surface of the lens had multilayer epithelial cells
in transgenic mice. The scale bars are equal to 50 µm. Abbreviations: L, lens; C, lens capsule; A, anterior epithelium of lens; AC, anterior
chamber; ir, iris; S, corneal stroma; En, corneal endothelium.
1948An exogenous transgene in the transgenic mouse model
should be clearly distinct from an endogenous gene. For this,
many researchers use specific marker genes or the same gene
from different species. By using the human βigh3 transgene,
exogenous transgene is easily distinguished from endogenous
mouse βigh3. Since the nucleotide sequence of human βigh3
has high identity with mouse βigh3 and the amino acid se-
quence also has more than 91% identity with mouse, there
were no undesirable phenotypes caused by using a transgene
from a different species.
Here, we demonstrated that the Alb-hβigh3 transgenic
mouse had a serious failure in anterior segment development
including an irregularity of the corneal epithelium, disorgani-
zation in collagen layer of the corneal stroma, and discontinu-
ity of corneal endothelium following corneal opacity. Thick-
ened corneal abnormality due to endothelial disruption was
observed in the cornea of Alb-hβigh3 transgenic mice with
corneal opacity. Moreover, the attachment of the iris or lens to
the cornea in some transgenic mice indicated that
overexpression of βigh3 resulted in incomplete central migra-
tion of neural crest cells during ocular development. Cataract
formation was also examined in defective eyes of Alb-hβigh3
transgenic mice. In a previous paper, we showed that βigh3
expression greatly increased in lens epithelial cells from pa-
tients with anterior polar cataracts and in human lens epithe-
lial cells treated with TGF-β [30]. Thus, cataract formation in
transgenic mice was due to overexpression of βigh3 in their
affected eyes. The bilateral phenotype with cataract in Alb-
hβigh3 transgenic mice was very similar to the clinicopatho-
logic findings of Peters’ anomaly that is a kind of anterior
mesenchymal dysgenesis in human developmental anomalies.
Most cases of Peters’ anomaly are bilateral with lens abnor-
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Figure 6. Histological examination of the defective eye in transgenic mouse compared to normal eye in wild-type mouse at two months of age.
Staining was performed with H&E in each 4 µm thick paraffin sections. C is the serial section of B. Images in rows 2 and 3 are higher-
magnification images of the cornea corresponding to the two red rectangles in column 1. The abnormal cornea of transgenic mice (B, C) had
disorganized corneal stroma and disconnected Descemet’s membrane and endothelial cell layer compared to wild-type (A). The scale bars are
equal to 50 µm. Abbreviations: L, Lens; ir, iris; AC, anterior chamber; Ep, corneal epithelium; S, corneal stroma; En, corneal endothelium.
1949mality and variable severity [31,32]. However, mild unilat-
eral cases are often observed in patients who do not have cata-
ract. Additionally, even though hβigh3 was overexpressed in
the entire mouse body through the blood stream, the effect
was observed only in the eye. This result corresponds exactly
with the observation that mutant βigh3 in humans causes only
corneal dystrophy in the eye and no other deformities in other
organs [33].
The anterior segment of the vertebrate eye is structurally
defined by the cornea, iris, ciliary body, and lens [34]. Various
anterior segment mesenchymal dysgenesis have been reported
in humans and animals. In particular, anterior segment disor-
ders in humans include autosomal dominant
iridogoniodysgenesis anomaly, family glaucoma with
goniodysgenesis, congenital endothelial dystrophy, and aniri-
dia [35-38]. Although coordinated interactions between dif-
ferent cell types in these disorders are considered essential for
proper spatial positioning and differentiation, the requisite
intercellular signals and the proper animal model to verify these
signals have not been well defined. One human anterior seg-
ment disorder, Peters’ anomaly, is characterized by congenital
corneal opacity with defects in the cornea [39]. By histologi-
cal examination, Peters’ anomaly in humans shows dense cor-
neal opacity, iridocorneal adhesions, and occasional lens ab-
normality with direct adhesion to the posterior corneal sur-
face. In addition, human Peters’ anomaly accounts for a thick-
ened cornea due to endothelial layer disruption. The histo-
logical views of Alb-hβigh3 transgenic mice with corneal opac-
ity are comparable to phenotypes observed in human Peters’
anomaly. Likewise, a mouse model of fetal alcohol syndrome
(FAS) has been reported to exhibit similar defects to Peters’
anomaly with malformations in Descemet’s membrane and
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Figure 7. Histologic analysis of the
anterior segment in a seven-month-
old Alb-hβigh3 transgenic mouse.
Staining was performed with H&E
(A, C, and E) and Trichrome (B, D,
and F) in each 4 µm thick paraffin
section. Images in rows 2 and 3 are
higher-magnification images corre-
sponding to the small rectangles in
column 1. Separation between lens
and cornea was not complete in the
defective eye of the Alb-hβigh3
transgenic mouse. The attached por-
tion between the protruded lens and
cornea showed proliferated lens epi-
thelial cell under the lens capsule. The
terminal part of the iris was attached
to the posterior surface of the cornea
and there was no space for the ante-
rior chamber. E shows the normal eye
of a seven-month-old wild-type
mouse. The scale bars are equal to 50
µm. Abbreviations: L, Lens; C, lens
capsule; A, anterior epithelium of
lens; ir, iris; Ep, corneal epithelium;
S, corneal stroma; En, corneal endot-
helium.
1950corneal endothelium as well as delayed or failed separation of
the lens [40]. Accordingly, Alb-hβigh3 transgenic mice will
be a practical model to study these eye disorders.
Though we have not examined the signaling pathway that
is altered by overexpression of βigh3, these results sufficiently
explain that βigh3 is involved in anterior segment morpho-
genesis and must be properly expressed for normal anterior
segment development. This suggests that βigh3 may play an
important role in the corneolenticular adhesion and the nor-
mal development of the cornea during ocular morphogenesis.
Therefore, βigh3 may play a role in the normal formation of
the anterior segment. Taken together, this study shows that
βigh3 expression must be critically maintained during ocular
development to avoid severe deformity, especially in the cor-
nea. The Alb-hβigh3 transgenic mice described in this study
also provide a useful animal model for the study of anterior
segment dysgenesis and of the control of proliferation and dif-
ferentiation of neural crest-originated cells.
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